BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32348778)

  • 1. Characterization of cancer-related somatic mutations in the adenosine A
    Wang X; Jespers W; Bongers BJ; Habben Jansen MCC; Stangenberger CM; Dilweg MA; Gutiérrez-de-Terán H; IJzerman AP; Heitman LH; van Westen GJP
    Eur J Pharmacol; 2020 Aug; 880():173126. PubMed ID: 32348778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
    Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
    FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.
    Liu R; Nahon D; le Roy B; Lenselink EB; IJzerman AP
    Biochem Pharmacol; 2015 Jun; 95(4):290-300. PubMed ID: 25896847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.
    Peeters MC; Li Q; Elands R; van Westen GJ; Lenselink EB; Müller CE; IJzerman AP
    Biochem Pharmacol; 2014 Nov; 92(2):348-57. PubMed ID: 25179146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.
    Hajiahmadi S; Panjehpour M; Aghaei M; Shabani M
    Biochem Cell Biol; 2015 Aug; 93(4):321-9. PubMed ID: 25877700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells.
    Darashchonak N; Koepsell B; Bogdanova N; von Versen-Höynck F
    BMC Pregnancy Childbirth; 2014 Jan; 14():2. PubMed ID: 24383849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.
    Beukers MW; van Oppenraaij J; van der Hoorn PP; Blad CC; den Dulk H; Brouwer J; IJzerman AP
    Mol Pharmacol; 2004 Mar; 65(3):702-10. PubMed ID: 14978249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor.
    Bertheleme N; Singh S; Dowell SJ; Hubbard J; Byrne B
    Br J Pharmacol; 2013 Jul; 169(5):988-98. PubMed ID: 23489072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S; Lacher SK; Seibt BF; Müller CE
    J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade.
    Donoso MV; López R; Miranda R; Briones R; Huidobro-Toro JP
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2439-49. PubMed ID: 15637124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.
    Nayak S; Khan MA; Wan TC; Pei H; Linden J; Dwinell MR; Geurts AM; Imig JD; Auchampach JA
    Purinergic Signal; 2015 Dec; 11(4):519-31. PubMed ID: 26385692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related somatic mutations alter adenosine A
    Wang X; Jespers W; de Waal JJ; Wolff KAN; van Uden L; IJzerman AP; van Westen GJP; Heitman LH
    FASEB J; 2022 Jun; 36(6):e22358. PubMed ID: 35604751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.
    Li Q; Ye K; Blad CC; den Dulk H; Brouwer J; Ijzerman AP; Beukers MW
    J Pharmacol Exp Ther; 2007 Feb; 320(2):637-45. PubMed ID: 17077318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
    Kuno A; Critz SD; Cui L; Solodushko V; Yang XM; Krahn T; Albrecht B; Philipp S; Cohen MV; Downey JM
    J Mol Cell Cardiol; 2007 Sep; 43(3):262-71. PubMed ID: 17632123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
    Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
    J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.